Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Venus Remedies

BSE: 526953|NSE: VENUSREM|ISIN: INE411B01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 20, 14:28
23.85
0.1 (0.42%)
VOLUME 551
LIVE
NSE
Nov 20, 14:49
23.30
-0.15 (-0.64%)
VOLUME 2,334
Announcements on Venus Remedies

12th-Nov-2019 19:54Source: BSE

Venus Remedies- Standalone & Consolidated Unaudited Financial Results For The Quarter Ended On 30.09.2019.

Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30.09.2019.

12th-Nov-2019 19:40Source: BSE

Venus Remedies- Outcome of Board Meeting

This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved Standalone & Consolidated Unaudited Financial Results for the quarter end...

2nd-Nov-2019 16:29Source: BSE

Venus Remedies- Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication for Notice of Board meeting to be held on 12.11.2019.

31st-Oct-2019 18:04Source: BSE

Venus Remedies- Board Meeting Intimation for The Meeting Of Board Of Directors Is Scheduled To Be Held On Tuesday, 12Th November 2019.

VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve This is to inform you that the meeting of ...

29th-Oct-2019 14:21Source: BSE

Venus Remedies- Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Certificate under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

18th-Oct-2019 11:34Source: NSE

Venus Remedies Limited

Significant movement in price has been observed in Venus Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market p...

18th-Oct-2019 08:00Source: BSE

Venus Remedies- Clarification sought from Venus Remedies Ltd

The Exchange has sought clarification from Venus Remedies Ltd on 17th October 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information a...

17th-Oct-2019 19:10Source: BSE

Venus Remedies- Venus Announces Deal With Cipla For Its Patented Product Elores For Indian Territory

Venus announces deal with Cipla for its patented product Elores for Indian Territory

5th-Oct-2019 15:33Source: BSE

Venus Remedies- Disclosure Of Revised Voting Results Of 30Th Annual General Meeting Of The Company

Requirements) Regulations, 2015, Pls. find enclosed herewith revised Voting Results of 30th Annual General Meeting of the Company along with revised annexure to the scrutinizer report dated 30.09.2019...

28th-Sep-2019 19:30Source: BSE

Venus Remedies- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 28, 2019 for Pawan Chaudhary

1 2 3 4 5 Next >>
Quick Links for Venus Remedies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.